న్యూరోఎండోక్రైన్ ట్యూమర్

Gastro-enteropancreatic Neuro-endocrine tumors (GEP-NETs) are rare slow-growing cancers which commonly involve the abdominal organs like liver, stomach, intestines and pancreas. Their incidence has been documented to have increased over the last decade, thus resulting in treatment options being developed to treat these cancers. These cancers spread commonly to the liver, followed by lungs, bones and other sites. Depending on the extent of disease seen on scan, treatment is planned. Patients are advised Peptide Receptor Radionuclide Therapy (PRRT), which is the current standard of treatment for…

స్పాన్సర్: టాటా మెమోరియల్ హాస్పిటల్
NCT07404176 on ClinicalTrials.gov
రిజిస్ట్రీలో చివరి అప్‌డేట్ 11 Feb 2026 · మేము చదివినది 20 Oct 2026